Policy #: 069 Latest Review Date: November 2009 Policy Grade: Active Policy but no longer scheduled for regular literature reviews and updates.

Similar documents
Name of Policy: Sympathetic Therapy and Bioelectrical Nerve Block or Electroanalgesic Nerve Block for the Treatment of Pain

Policy #: 049 Latest Review Date: April 2009 Policy Grade: Active policy but no longer scheduled for regular literature reviews and update.

Name of Policy: Computerized Pulse Waveform Analysis

Policy #: 222 Latest Review Date: March 2009

Name of Policy: Magnetic Resonance Neurography

Name of Policy: Computer-aided Detection (CAD) Mammography

Name of Policy: Boniva (Ibandronate Sodium) Infusion

Name of Policy: Yervoy (Ipilimumab)

Name of Policy: Measurement of Long-Chain Omega-3 Fatty Acids in Red Blood Cell Membranes as a Cardiac Risk Factor

Policy #: 291 Latest Review Date: February 2013

Name of Policy: Zoledronic Acid (Reclast ) Injection

Policy #: 370 Latest Review Date: December 2013

Name of Policy: Pulsed Dye Laser Treatment of Recalcitrant Verrucae

Policy #: 370 Latest Review Date: April 2017

Name of Policy: Reduction Mammaplasty

Policy #: 259 Latest Review Date: November 2009

Name of Policy: Panitumumab, Vectibix

Policy #: 127 Latest Review Date: June 2011

Policy #: 120 Latest Review Date: June 2009

Policy #: 668 Effective Date: December 1, 2016 Category: Pharmacology Latest Review Date: September 2016

Name of Policy: Speculoscopy

Name of Policy: Therapeutic Apheresis, with Extracorporeal Column Immunoadsorption and Plasma Reinfusion

Policy #: 213 Latest Review Date: September 2012

Name of Policy: Transurethral Microwave Thermotherapy

Name of Policy: Sensory Integration Therapy, Auditory Integration Therapy and Facilitated Communication

Corporate Medical Policy

Name of Policy: Vertical Expandable Prosthetic Titanium Rib

Name of Policy: Paraspinal Surface Electromyography (SEMG) to Evaluate and Monitor Back Pain

Corporate Medical Policy Automated Percutaneous and Endoscopic Discectomy

MEDICAL POLICY Acupuncture

Name of Policy: Hematopoietic Stem-Cell Transplantation for Epithelial Ovarian Cancer

Effective for dates of service on or after April 1, 2013, refer to:

Corporate Medical Policy

Name of Policy: Laboratory Tests of Sperm Maturity, Function and DNA Integrity

Effective for dates of service on or after April 1, 2013, refer to:

Corporate Medical Policy

Partial Coherence Interferometry as a Technique to Measure the Axial Length of the Eye Archived Medical Policy

Name of Policy: Ovarian and Internal Iliac Vein Embolization as Treatment of Pelvic Congestion Syndrome

Medical Policy Vertebral Axial Decompression Section 8.0 Therapy Subsection 8.03 Rehabilitation. Description. Related Policies.

Original Policy Date

Corporate Medical Policy

Low back pain, radiculopathy left leg icd 10 code

Corporate Medical Policy

Corporate Medical Policy

Name of Policy: Cellular Immunotherapy for Prostate Cancer

Corporate Medical Policy

Jurisdiction New Mexico. Retirement Date N/A

Local Coverage Determination (LCD) for Chiropractic Services (L34816) (Posted for Notice)

Corporate Medical Policy

Vertebral Axial Decompression

National Imaging Associates, Inc. Clinical guidelines CHIROPRACTIC SERVICES. Original Date: Page 1 of FOR CMS (MEDICARE) MEMBERS ONLY

Name of Policy: Mobile Cardiac Outpatient Telemetry and Hybrid Devices

vedolizumab (Entyvio )

Corporate Medical Policy

Corporate Medical Policy Investigational (Experimental) Services

Jurisdiction Georgia. Retirement Date N/A

Interventional Pain Management

Percutaneous Discectomy

Vertebral Axial Decompression

Implantable Hormone Pellets

Cryosurgical Ablation of Breast Fibroadenomas

tens_(transcutaneous_electrical_nerve_stimulator) 7/ / / /2014 This policy is NOT effective until January 13, 2015

Clinical Policy: Disc Decompression Procedures Reference Number: CP.MP.114

burosumab (Crysvita )

Spinal ultrasound is considered medically necessary for ANY of the following indications:

Mountain State Blue Cross Blue Shield (Otherwise referred to as the Plan) CORPORATE POLICY AND PROCEDURES

Lower back pain with radiculopathy icd 10

Policy Specific Section:

Vertebral Axial Decompression

SPINAL ULTRASONOGRAPHY

Cervical Disc Arthroplasty Reimbursement Guide

Nonsurgical Interventional Treatments for Spinal Pain Management

Policy #: 436 Latest Review Date: September 2016

PERCUTANEOUS FACET JOINT DENERVATION

denosumab (Prolia ) Policy # Original Effective Date: 07/21/2011 Current Effective Date: 04/19/2017

Based on review of available data, the Company may consider the use of denosumab (Prolia) for the

SPINAL ULTRASONOGRAPHY

Payment Policy. Chiropractic Care. Policy Specific Section: September 10, 2012 November 10, 2012

MP.094.MH Transcutaneous Electrical Nerve Stimulators

Clinical Policy: Facet Joint Interventions

Subject: Non-Invasive Electrical Bone Growth Stimulators (EBGS)

Policy #: 138 Latest Review Date: November 2016

Corporate Medical Policy

Zurampic, Duzallo (lesinurad Products)

NEUROABLATION FOR TREATMENT OF CHRONIC PAIN

Soliris Medical Policy Prior Authorization Program Summary

Corporate Medical Policy

Icd 9 lumbar radiculopathy

Clinical Policy: Disc Decompression Procedures Reference Number: CP.MP.114

2017 Blue Cross and Blue Shield of Louisiana

Contractor Information

A M E R I C A N A R B I T R A T I O N A S S O C I A T I O N NO-FAULT/ACCIDENT CLAIMS AWARD OF DISPUTE RESOLUTION PROFESSIONAL

Chiropractic ICD-10 Common Codes List

droxidopa (Northera )

Clinical Policy: Cochlear Implant Replacements Reference Number: CP.MP.14

and will be denied as not medically necessary** if not met. This criterion only applies to the initial

Original Date: October 2015 LUMBAR SPINAL FUSION FOR

Corporate Medical Policy

Transcription:

Name of Policy: Ultrasound of the Spinal Canal Policy #: 069 Latest Review Date: November 2009 Category: Radiology Policy Grade: Active Policy but no longer scheduled for regular literature reviews and updates. Background/Definitions: As a general rule, benefits are payable under Blue Cross and Blue Shield of Alabama health plans only in cases of medical necessity and only if services or supplies are not investigational, provided the customer group contracts have such coverage. The following Association Technology Evaluation Criteria must be met for a service/supply to be considered for coverage: 1. The technology must have final approval from the appropriate government regulatory bodies; 2. The scientific evidence must permit conclusions concerning the effect of the technology on health outcomes; 3. The technology must improve the net health outcome; 4. The technology must be as beneficial as any established alternatives; 5. The improvement must be attainable outside the investigational setting. Medical Necessity means that health care services (e.g., procedures, treatments, supplies, devices, equipment, facilities or drugs) that a physician, exercising prudent clinical judgment, would provide to a patient for the purpose of preventing, evaluating, diagnosing or treating an illness, injury or disease or its symptoms, and that are: 1. In accordance with generally accepted standards of medical practice; and 2. Clinically appropriate in terms of type, frequency, extent, site and duration and considered effective for the patient s illness, injury or disease; and 3. Not primarily for the convenience of the patient, physician or other health care provider; and 4. Not more costly than an alternative service or sequence of services at least as likely to produce equivalent therapeutic or diagnostic results as to the diagnosis or treatment of that patient s illness, injury or disease. Page 1 of 5

Description of Procedure or Service: Ultrasound is a technique used to visualize structures deep within the body by recording echoes of ultrasonic wave pulses directed into the tissues. The sonic pulses have a frequency of between 1 and 10 megahertz, which are transmissible only through liquids or solids. There are several variations in technique for ultrasonography, such as continuous-wave Doppler echography, pulsed wave Doppler echography, and gray-scale echography. Policy: Ultrasound of the spinal column meets Blue Cross and Blue Shield of Alabama s medical criteria for coverage in infants less than one year to evaluate the spinal canal for defects (i.e., spina bifida). Ultrasound of the spinal column does not meet Blue Cross and Blue Shield of Alabama s medical criteria for coverage and is considered investigational when the ultrasound is used for diagnosis of painful musculoskeletal conditions (e.g., sprain, strain, lumbago, myalgia, back pain, subluxation, scoliosis, sciatica, intervertebral disc displacement). Blue Cross and Blue Shield of Alabama does not approve or deny procedures, services, testing, or equipment for our members. Our decisions concern coverage only. The decision of whether or not to have a certain test, treatment or procedure is one made between the physician and his/her patient. Blue Cross and Blue Shield of Alabama administers benefits based on the members' contract and corporate medical policies. Physicians should always exercise their best medical judgment in providing the care they feel is most appropriate for their patients. Needed care should not be delayed or refused because of a coverage determination. Key Points: In 1995, the American Institute of Ultrasound Medicine (AIUM) issued the following statement: The AIUM recognizes that diagnostic ultrasound is a valuable tool in certain neonatal, fetal, perinatal, pediatric, neurologic and musculoskeletal disorders.there is insufficient evidence in the peer-reviewed medical literature establishing the value of diagnostic spinal ultrasound (for study of facet joints and capsules, nerve and fascial edema, and other subtle paraspinous abnormalities) for diagnostic evaluation, for evaluation of pain or radiculopathy syndromes, and monitoring of therapy has no proven clinical utility.diagnostic spinal ultrasound should be considered investigational. In 1996, the American College of Radiology also issued this statement regarding the use of ultrasound technology for the evaluation of the spine and paraspinal regions in adults: While diagnostic ultrasound is appropriately used, 1) intraoperatively; 2) in the newborn and infants for the evaluation of the sinal cord and canal; and 3) for multiple musculoskeletal application in adults, there is currently no documented scientific evidence of the efficacy of this modality in the evaluation of the paraspinal tissues and the spine in adults. In 1996, the American Chiropractic Association issued the following statement regarding diagnostic spinal ultrasound: Page 2 of 5

The application of diagnostic ultrasound in the adult spine in areas such as disc herniation, spinal stenosis and nerve root pathology is inadequately studied and its routine application for these purposes cannot be supported by the evidence at this time. In June, the American Institute of Ultrasound in Medicine approved the following statement on Nonoperative Spinal/Paraspinal Ultrasound in Adults : There is insufficient evidence in the peer-reviewed medical literature establishing the value of non-operative spinal/paraspinal ultrasound in adults. Therefore, the AIUM states that, at this time, the use of non-operative spinal/paraspinal ultrasound in adults (for study of facet joints and capsules, nerve and fascial edema, and other subtle paraspinous abnormalities) for diagnostic evaluation, for evaluation of pain or radiculopathy syndromes, and for monitoring of therapy has no proven clinical utility. Nonoperative spinal/paraspinal ultrasound in adults should be considered investigational. The AIUM urges investigators to perform proper double-blind research projects to evaluate the efficacy of these diagnostic spinal ultrasound examinations. The AIUM endorses the American College of Radiology 2001 position statement on Nonoperative Spinal/Paraspinal Ultrasound in Adults. November 2009 A review of the specialty societies recommendations have remained the same: The American Academy of Neurology (AAN) no new updates, American Chiropractic Association and the American Chiropractic College of Radiology Guideline reviewed and re-adopted, 2005. The American Institute of Ultrasound in Medicine (AIUM) approved the following statement in April 2009: There is insufficient evidence in the peer-reviewed medical literature establishing the value of non-operative spinal/paraspinal ultrasound in adults (for study of intervertebral discs, facet joint and capsules, central nerves and fascial edema, and other subtle paraspinous abnormalities) for screening, diagnostic evaluation, including pain or radiculopathy syndromes, and for monitoring of therapy has no proven clinical utility. Non-operative spinal/paraspinal ultrasound in adults should be considered investigational. The AIUM urges investigators to perform properly designed research projects to evaluate the efficacy of these diagnostic spinal ultrasound examinations. The policy statement remains unchanged. Key Words: Ultrasound, spinal column, echography, diagnostic ultrasound Approved by Governing Bodies: Not applicable Page 3 of 5

Benefit Application: Coverage is subject to member s specific benefits. Group specific policy will supersede this policy when applicable. ITS: Home Policy provisions apply FEP contracts: Special benefit consideration may apply. Refer to member s benefit plan. FEP does not consider investigational if FDA approved. Will be reviewed for medical necessity. Pre-certification/Pre-determination requirements: Not applicable Current Coding: CPT codes: 76800 Ultrasound, spinal canal and contents References: 1. American Chiropractic Association. ACCR Guideline for the Use of Diagnostic spinal Ultrasound. American Chiropractic College of Radiology 2005. 2. American Institute of Ultrasound in Medicine. Nonoperative spinal/paraspinal ultrasound in adults. June 2002. http://www.aium.org. 3. American Institute of Ultrasound in Medicine. Nonoperative spinal/paraspinal ultrasound in adults, April 6, 2009. http://www.aium.org/publications/statements.aspx. Accessed September 28, 2009. 4. CareFirst Blue Cross Blue Shield, Medical Policy Reference Manual, Ultrasound (Echography) of the spinal canal and contents, September 30, 2001. 5. Gerscovich, Eugenio O., and McGahan, John P. Ultrasound of the spinal canal in the young child, Applied Radiology, March 2001, Vol. 30, No. 3. 6. Nazarian, Levon N., Zegel, Harry G., et al. Paraspinal ultrasonography: Lack of accuracy in evaluating patients with cervical or lumbar back pain, J Ultrasound Med, 1998, 17:117-122. 7. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Review of the literature on spinal ultrasound for the evaluation of back pain and radicular disorders, Neurology, August 1998, Vol. 51, No. 2, pp. 343-344. Medical Policy Group, October 2002 (1) Policy History: Medical Policy Administration Committee, October 2002 Available for comment November 13-December 26, 2002 Medical Policy Group, November 2005 (1) Medical Policy Group, November 2007 (1) Medical Policy Group, November 2009 (1) Medical Policy Group, September 2012 (3): Active Policy but no longer scheduled for regular literature reviews and updates. Page 4 of 5

This medical policy is not an authorization, certification, explanation of benefits, or a contract. Eligibility and benefits are determined on a caseby-case basis according to the terms of the member s plan in effect as of the date services are rendered. All medical policies are based on (i) research of current medical literature and (ii) review of common medical practices in the treatment and diagnosis of disease as of the date hereof. Physicians and other providers are solely responsible for all aspects of medical care and treatment, including the type, quality, and levels of care and treatment. This policy is intended to be used for adjudication of claims (including pre-admission certification, pre-determinations, and pre-procedure review)in Blue Cross and Blue Shield s administration of plan contracts. Page 5 of 5